Delivery Order SPE2DB20D9637-SPE2DB23FC9PQ

Award Date 7/28/23

Potential Completion Date 8/18/23

Potential Value $8.2K

Federal Agency

Defense Logistics Agency

Awardee

DMS Pharmaceutical Group Inc. PX72BSBQTKJ3

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Park Ridge, IL 60068, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The Defense Logistics Agency awarded a $8,204.88 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to provide 68 mg Nexplanon implants. The Defense Logistics Agency procures medical supplies and equipment for the U.S. Department of Defense. DMS Pharmaceutical Group will deliver the Nexplanon implants to a location in Park Ridge, Illinois between July 28, 2023 and August 18, 2023 to support the Defense Logistics Agency's medical supply needs. No major subcontractors or set aside designations were identified in the award information.

Generated 12/23/23, 6:17 AM